Chesley Taft & Associates LLC decreased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 2.4% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 28,367 shares of the company’s stock after selling 705 shares during the quarter. Chesley Taft & Associates LLC’s holdings in Colgate-Palmolive were worth $2,140,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the company. Blue Chip Partners Inc. raised its position in shares of Colgate-Palmolive by 0.4% in the 2nd quarter. Blue Chip Partners Inc. now owns 1,813 shares of the company’s stock worth $134,000 after buying an additional 8 shares during the period. AlphaMark Advisors LLC raised its position in shares of Colgate-Palmolive by 1.5% in the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after buying an additional 25 shares during the period. Weatherstone Capital Management raised its position in shares of Colgate-Palmolive by 0.7% in the 2nd quarter. Weatherstone Capital Management now owns 4,069 shares of the company’s stock worth $302,000 after buying an additional 28 shares during the period. Dorsey & Whitney Trust CO LLC raised its position in shares of Colgate-Palmolive by 0.6% in the 2nd quarter. Dorsey & Whitney Trust CO LLC now owns 5,642 shares of the company’s stock worth $419,000 after buying an additional 34 shares during the period. Finally, Jackson Grant Investment Advisers Inc. raised its position in shares of Colgate-Palmolive by 0.5% in the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 7,028 shares of the company’s stock worth $521,000 after buying an additional 35 shares during the period. Institutional investors and hedge funds own 72.85% of the company’s stock.

CL has been the topic of several research reports. Citigroup cut their target price on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a research report on Thursday, November 2nd. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price objective on the stock in a research report on Monday, October 23rd. KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Macquarie raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective on the stock in a research report on Tuesday, December 19th. Finally, SunTrust Banks raised Colgate-Palmolive from a “hold” rating to a “buy” rating and raised their price objective for the company from $65.00 to $85.00 in a research report on Wednesday, October 11th. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and six have assigned a buy rating to the stock. Colgate-Palmolive has a consensus rating of “Hold” and an average target price of $76.45.

In other news, Director Stephen I. Sadove sold 20,780 shares of the firm’s stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the completion of the sale, the director now directly owns 36,268 shares in the company, valued at $2,557,619.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jennifer Daniels sold 902 shares of the firm’s stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $75.82, for a total value of $68,389.64. Following the sale, the insider now owns 37,788 shares of the company’s stock, valued at $2,865,086.16. The disclosure for this sale can be found here. Insiders have sold 181,950 shares of company stock valued at $13,237,385 over the last 90 days. Insiders own 1.02% of the company’s stock.

Shares of Colgate-Palmolive (NYSE:CL) opened at $76.90 on Wednesday. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. The firm has a market capitalization of $67,530.00, a PE ratio of 29.69, a PEG ratio of 3.24 and a beta of 0.81. Colgate-Palmolive has a 52 week low of $63.43 and a 52 week high of $77.91.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, meeting the consensus estimate of $0.73. The company had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The company’s revenue was up 2.8% on a year-over-year basis. During the same period last year, the firm earned $0.73 earnings per share. sell-side analysts predict that Colgate-Palmolive will post 2.87 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd will be paid a dividend of $0.40 per share. The ex-dividend date is Monday, January 22nd. This represents a $1.60 annualized dividend and a dividend yield of 2.08%. Colgate-Palmolive’s dividend payout ratio is presently 61.78%.

COPYRIGHT VIOLATION NOTICE: “Chesley Taft & Associates LLC Has $2.14 Million Stake in Colgate-Palmolive (CL)” was first posted by Daily Political and is owned by of Daily Political. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international copyright legislation. The correct version of this news story can be viewed at https://www.dailypolitical.com/2018/01/24/chesley-taft-associates-llc-has-2-14-million-stake-in-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.